BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16343526)

  • 1. A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.
    Gómez-Román VR; Florese RH; Patterson LJ; Peng B; Venzon D; Aldrich K; Robert-Guroff M
    J Immunol Methods; 2006 Jan; 308(1-2):53-67. PubMed ID: 16343526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity.
    Kramski M; Schorcht A; Johnston AP; Lichtfuss GF; Jegaskanda S; De Rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ
    J Immunol Methods; 2012 Oct; 384(1-2):51-61. PubMed ID: 22841577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS.
    Banks ND; Kinsey N; Clements J; Hildreth JE
    AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1197-205. PubMed ID: 12487826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement and neutralization pattern of sera from SIV-infected or HIV-2-vaccinated rhesus monkeys.
    Le Grand R; Vogt G; Chapel A; Dormont D
    J Med Primatol; 1991 Jun; 20(4):172-6. PubMed ID: 1942007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
    Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
    Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity.
    Alrubayyi A; Schuetz A; Lal KG; Jongrakthaitae S; Paolino KM; Ake JA; Robb ML; de Souza MS; Michael NL; Paquin-Proulx D; Eller MA
    J Immunol Methods; 2018 Nov; 462():74-82. PubMed ID: 30148978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies.
    Orlandi C; Flinko R; Lewis GK
    J Immunol Methods; 2016 Jun; 433():51-8. PubMed ID: 26969387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HIV-specific antibody-dependent cellular cytotoxicity in HIV prevention and the influence of the HIV-1 Vpu protein.
    Kramski M; Stratov I; Kent SJ
    AIDS; 2015 Jan; 29(2):137-44. PubMed ID: 25396265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
    Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
    J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity to clinical isolates of HIV-1 and SIVcpz: comparison of human and chimpanzees.
    Broliden K; Hinkula J; Tolfvenstam T; Niphuis H; Heeney J
    AIDS; 1996 Sep; 10(11):1199-204. PubMed ID: 8883580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc receptor but not complement binding is important in antibody protection against HIV.
    Hessell AJ; Hangartner L; Hunter M; Havenith CE; Beurskens FJ; Bakker JM; Lanigan CM; Landucci G; Forthal DN; Parren PW; Marx PA; Burton DR
    Nature; 2007 Sep; 449(7158):101-4. PubMed ID: 17805298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.
    Tsukamoto T; Yuasa M; Yamamoto H; Kawada M; Takeda A; Igarashi H; Matano T
    J Virol; 2007 Nov; 81(21):11640-9. PubMed ID: 17728225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys.
    Sun Y; Asmal M; Lane S; Permar SR; Schmidt SD; Mascola JR; Letvin NL
    J Virol; 2011 Jul; 85(14):6906-12. PubMed ID: 21593181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming B cell-mediated anti-HIV envelope responses by vaccination allows for the long-term control of infection in macaques exposed to a R5-tropic SHIV.
    Buckner C; Gines LG; Saunders CJ; Vojtech L; Srivastava I; Gettie A; Bohm R; Blanchard J; Barnett SW; Safrit JT; Stamatatos L
    Virology; 2004 Mar; 320(1):167-80. PubMed ID: 15003872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model.
    Suh YS; Park KS; Sauermann U; Franz M; Norley S; Wilfingseder D; Stoiber H; Fagrouch Z; Heeney J; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2006 Mar; 24(11):1811-20. PubMed ID: 16274888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.
    Kramski M; Lichtfuss GF; Navis M; Isitman G; Wren L; Rawlin G; Center RJ; Jaworowski A; Kent SJ; Purcell DF
    Eur J Immunol; 2012 Oct; 42(10):2771-81. PubMed ID: 22730083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal exposure to subinfectious doses of SIV primes gut-associated antibody-secreting cells and T cells: lack of enhancement by nonneutralizing antibody.
    Polyanskaya N; Bergmeier LA; Sharpe SA; Cook N; Leech S; Hall G; Dennis M; ten Haaft P; Heeney J; Manca F; Lehner T; Cranage MP
    Virology; 2001 Jan; 279(2):527-38. PubMed ID: 11162808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.